Detalhe da pesquisa
1.
Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial.
Ann Oncol
; 35(3): 293-301, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38092228
2.
Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer.
Ann Oncol
; 34(9): 783-795, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37302750
3.
Therapeutic cancer vaccines revamping: technology advancements and pitfalls.
Ann Oncol
; 32(12): 1537-1551, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34500046
4.
The immune profile of small HER2-positive breast cancers: a secondary analysis from the APT trial.
Ann Oncol
; 30(4): 575-581, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30753274
5.
OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer Patients.
Ann Surg Oncol
; 26(3): 815-820, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30556120
6.
Multidisciplinary Intraoperative Assessment of Breast Specimens Reduces Number of Positive Margins.
Ann Surg Oncol
; 25(10): 2932-2938, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29947001
7.
Clinical and pathological features of breast cancer patients eligible for adjuvant abemaciclib.
Ann Oncol
; 33(8): 845-847, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35525374
8.
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence.
Ann Oncol
; 27(7): 1241-8, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27029708
9.
Clinicopathological and surgical factors associated with long-term survival in patients with HER2-positive metastatic breast cancer.
Breast Cancer Res Treat
; 159(2): 367-74, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27522517
10.
Effect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapy.
Br J Cancer
; 112(4): 630-5, 2015 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-25584488
11.
Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients.
Ann Oncol
; 25(9): 1735-1742, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24907636
12.
Which threshold for ER positivity? a retrospective study based on 9639 patients.
Ann Oncol
; 25(5): 1004-11, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24562447
13.
Comparison of clinicopathologic features and survival in young American women aged 18-39 years in different ethnic groups with breast cancer.
Br J Cancer
; 109(5): 1302-9, 2013 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23907433
14.
Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer.
Ann Oncol
; 24(8): 1999-2004, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23562929
15.
Monitoring circulating tumor cells in cancer vaccine trials.
Hum Vaccin
; 4(5): 389-92, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18437056
16.
A feasibility study of neoadjuvant talazoparib for operable breast cancer patients with a germline BRCA mutation demonstrates marked activity.
NPJ Breast Cancer
; 3: 49, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29238749
17.
Thyroidectomy for selected patients with thyrotoxicosis.
Arch Otolaryngol Head Neck Surg
; 127(1): 61-5, 2001 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11177016
18.
Utility of intraoperative endoscopy: implications for surgical education.
Surg Endosc
; 16(4): 703-6, 2002 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-11972220
19.
Follow-up evaluation and clinical course of patients with benign nodular thyroid disease.
Am Surg
; 65(7): 653-7; discussion 657-8, 1999 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-10399975
20.
A novel interaction between HER2/neu and cyclin E in breast cancer.
Oncogene
; 29(27): 3896-907, 2010 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-20453888